Retatrutide, by Soma Pharmaceuticals , represents a promising advance in body regulation. This unique drug combines GLP-1 receptor function with another pathway activation , indicating remarkable potential in trial findings for weight loss . Researchers believe Retatrutide may provide a alternative solution for people struggling with excess weight